MUC5B, a Novel Therapeutic Target for Idiopathic Pulmonary Fibrosis (IPF)

Grant

Date/time Interval

  • January 1, 2015 - June 30, 2016
  • Awarded By

    Total Award Amount

  • 159516.00
  • Direct Costs

  • 108514.00
  • Sponsor Award Id

  • FY15.576.016
  • Contributor

  • Aaron Carter   Principal Investigator